$HIMS | BofA Securities maintains ๐๐๐ฎ๐ญ๐ซ๐๐ฅ on ๐๐ข๐ฆ๐ฌ & ๐๐๐ซ๐ฌ, ๐ซ๐๐ข๐ฌ๐๐ฌ ๐๐ ๐ญ๐จ $๐๐ ๐๐ซ๐จ๐ฆ $๐๐, 'This update is negative for the HIMS'
Analyst sees a recent FDA update as negative for HIMS's peptide optionality narrative, lowering the probability of a clear legal pathway for compounding.